There is progress to report in the Yaz and Yasmin multidistrict litigation (MDL No. 2100) currently underway in U.S. District Court for the Southern District of Illinois. Judge David Herndon, who is overseeing the Yaz and Yasmin MDL, has appointed members to the Plaintiffs’ Steering Committee.
The Plaintiffs’ Steering Committee was appointed by Judge Herndon in an Order dated November 10, 2009.
Dr Shezad Malik will be working closely with the members of the Plaintiffs’ Steering Committee.
Appointments to the Plaintiffs’ Steering Committee expire one year from the date of Judge Herndon’s order. Appointees to the Committee may apply to be reappointed at that time.
The Plaintiffs’ Steering Committee will, among other things, conduct and coordinate the discovery stage of this litigation with the defendants’ representatives or committee. The Committee will also act as a spokesperson for all plaintiffs at pretrial proceedings and in response to any inquiries by the Court.
More than 200 lawsuits have been filed by women across the United States who claim they suffered strokes, pulmonary emboli, deep vein thrombosis, blood clots, gallbladder disease, and other serious injuries after taking Yaz and Yasmin.
Yaz and Yasmin are both made with a progestin called drospirenone, making them different from many other oral contraceptives. Drospirenone can elevate the body’s potassium levels, which can lead to a condition called hyperkalemia in certain patients.
Yaz and Yasmin lawsuits allege that these sales were achieved through a marketing campaign that presented the medications as more than birth control pills, and touted them as treatments for premenstrual dysphoric disorder, premenstrual syndrome and moderate acne.
On October 1, 2009, all Yaz and Yasmin lawsuits pending in federal court were consolidated for centralized and coordinated pre-trial proceedings in the Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation in the United States District Court for the Southern District of Illinois before Judge Herndon (MDL No. 2100).
Medico-Legal News, Yaz, attorney yasmin, attorney yaz, birth control yasmin, birth control yaz, blood clots, dallas yasmin attorney, dallas yasmin law firm, dallas yaz attorney, dallas yaz law firm, deep vein thrombosis, drospirenone, gallbladder disease, lawyer yasmin, lawyer yaz, oral contraceptive, pulmonary embolism, side effects of yasmin, side effects of yaz, side effects yasmin, side effects yaz, yasmin, yasmin birth control, yasmin side effects, yasmine attorney, yasmine law firm, yasmine lawsuit, yasmine lawyer, yaz attorney, yaz birth control, yaz law firm, yaz lawsuit, yaz lawyer, yaz side effects.
acne attorney attorneys Bayer Bayer HealthCare BCP birth control cardiac arrest claims clinical studies clinical trials contraceptive drospirenone false advertising FDA FDA testing Food and Drug Administration heart attack hormone lawsuit lawsuits levonorgestrel PMDD PMS premenstrual dysphoric disorder progestin pulmonary embolism safety risks stroke thrombosis U.S. Food & Drug Administration Yasmin Yaz